Beactica Wins Grant to Develop Combination Therapy for Glioblastoma

Corporate Breaking News

Home : Beactica Wins Grant to Develop Combination Therapy for Glioblastoma

Jun 18 2019	Beactica Wins Grant to Develop Combination Therapy for Glioblastoma
STOCKHOLM, June 18, 2019 /PRNewswire/ -- Beactica AB, the Swedish drug discovery company, today announced that it has been awarded a grant of 2.8 MSEK (~$300 000) from SweLife and Medtech4Health for its project focused on finding effective therapies for glioblastoma, an aggressive form of ...


Source:https://www.prnewswire.com:443/news-releases/beactica-wins-grant-to-develop-combination-therapy-for-glioblastoma-300870101.html

Related News
» Public Pension Capital, 22C Capital and Viteos announce Viteos Acquisition by Intertrust N.V. » Collins Aerospace to improve the passenger processing experience and safeguard systems at Colombia's El Dorado International Airport